bpc-157 fda warning august 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Content Analysis of US FDA

The appeal of novel weight-loss compounds is understandable, but the risks of self-administering unlicensed injectables without medical oversight are substantial and should not be underestimated

K., Brzezik, J., Mdra-Gackowska, K., & Szeleszczuk,

Availability, current stock status, and batch documentation are shown directly on the linked product page

Your provider will determine the best combination based on your individual needs

Use in individuals under 18 is not recommended without specific medical supervision

As mentioned before, these were also angiogenesis-promoted in the CAM assay and the tube formation assay and accelerated the blood flow recovery and vessel number in rats with hind limb ischemia [94]